Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06050135 · ClinicalTrials.gov registry record · NA

Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer

A NA study of Quality of Life and Parenthood Status, sponsored by Stanford University.

Active
Registry status
NA
Development phase
260
Enrollment target
1
Study location

NCT06050135 is a NA study of Quality of Life and Parenthood Status that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 260 participants, below the 450-participant average among 107 other Quality of Life trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06050135, a NA study of Quality of Life and Parenthood Status, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
260 participants
Enrollment target
1
Study location

Study Summary

This study will test a decision support intervention that consists of a web-based 'decision aid and planning tool' for family building after cancer in a randomized controlled trial.

Interventions

  • OTHER Roadmap to Parenthood
  • OTHER Informational Booklet

Study Locations (1)

California

  • Stanford Universtiy - Palo Alto

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2024-05-20
Est. Completion 2027-02-10
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT06050135

The ClinicalTrials.gov registry entry for NCT06050135 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 450-participant average among 107 other Quality of Life trials with a reported enrollment target (42% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Quality of Life appearing as the primary indexed condition, and to 2 interventions - of which Roadmap to Parenthood is the first listed.

NCT06050135 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06050135 about?

NCT06050135 is a clinical study titled "Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer". This study will test a decision support intervention that consists of a web-based 'decision aid and planning tool' for family building after cancer in a randomized controlled trial.

What is the current status of trial NCT06050135?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 260 participants. The study started on 2024-05-20. Estimated completion is 2027-02-10.

What conditions does trial NCT06050135 study?

This clinical trial studies the following conditions: Quality of Life, Parenthood Status.

What interventions are being tested in trial NCT06050135?

The interventions under investigation include: Roadmap to Parenthood (OTHER), Informational Booklet (OTHER).

Who is sponsoring clinical trial NCT06050135?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06050135 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.